An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Gilead Sciences to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Gilead Sciences (Nasdaq: GILD) will present at key investor conferences including the Evercore ISI Annual HealthCONx Conference on November 29 at 1:00 PM ET, and the Piper Sandler Healthcare Conference on November 30 at 11:30 AM ET. Additionally, the Nasdaq Investor Conference is scheduled for December 7 at 1:00 PM GMT. Live webcasts can be accessed at investors.gilead.com, with replays available for 30 days.
Gilead has over three decades of experience in biopharmaceutical innovation, focusing on treatments for HIV, hepatitis, and cancer.
Positive
None.
Negative
None.
FOSTER CITY, Calif.--(BUSINESS WIRE)--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:
Evercore ISI Annual HealthCONx Conference on Tuesday, November 29 at 1:00 PM Eastern Time
Piper Sandler Healthcare Conference on Wednesday, November 30 at 11:30 AM Eastern Time
Nasdaq Investor Conference on Wednesday, December 7 at 1:00 PM Greenwich Mean Time
The live webcasts can be accessed at the company’s investors page at investors.gilead.com. The replays will be available for at least 30 days following the presentation.
About Gilead Sciences
Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.
What events will Gilead Sciences be presenting at in November 2023?
Gilead Sciences will present at the Evercore ISI Annual HealthCONx Conference on November 29, 2023, at 1:00 PM ET, and the Piper Sandler Healthcare Conference on November 30, 2023, at 11:30 AM ET.
When is the Nasdaq Investor Conference where Gilead will speak?
Gilead's presentation at the Nasdaq Investor Conference is scheduled for December 7, 2023, at 1:00 PM GMT.
How can I access Gilead's investor conference webcasts?
Live webcasts of Gilead's investor conferences can be accessed at their investors page: http://investors.gilead.com.
How long will Gilead's conference replays be available?
Replays of Gilead's presentations will be available for at least 30 days following each conference.
What is Gilead Sciences' focus in biopharmaceuticals?
Gilead Sciences focuses on developing innovative medicines for life-threatening diseases, including HIV, viral hepatitis, and cancer.
